ALVIN MENA CANTERO: Open Payments
NPI 1669845822 · FRESNO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,461 in 37 payments from 13 companies in 2025. Trend: 2023 $1,483 · 2024 $2,587 · 2025 $2,461
Food & beverage: $2,461
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $1,181 |
| GENZYME CORPORATION | 7 | $272 |
| GlaxoSmithKline, LLC. | 7 | $220 |
| Regeneron Healthcare Solutions, Inc. | 2 | $153 |
| Incyte Corporation | 1 | $125 |
| PFIZER INC. | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $109 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Blueprint Medicines Corporation | 1 | $30 |
Products named: AIRSUPRA, BREZTRI, DUPIXENT, FASENRA, Opzelura, NUCALA, CIBINQO, Ohtuvayre.
Industry payments across TX — which companies pay providers there.
